Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Marc Jean Lallemant, M.D.

TitleResearch Associate in Immunology and Infectious Diseases
InstitutionHarvard School of Public Health
DepartmentImmunology and Infectious Diseases
AddressHarvard School of Public Health
Bldg 2 RM 424
665 Huntington Ave
Boston MA 02115
Phone011660538191259

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Collins I, Cairns J, Le Coeur S, Pagdi K, Ngampiyaskul C, Layangool P, Borkird T, Na-Rajsima S, Wanchaitanawong V, Jourdain G, Lallemant M. Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand. J Acquir Immune Defic Syndr. 2013 Sep 1; 64(1):95-102.
    View in: PubMed
  2. Jourdain G, Le Cœur S, Ngo-Giang-Huong N, Traisathit P, Cressey TR, Fregonese F, Leurent B, Collins IJ, Techapornroong M, Banchongkit S, Buranabanjasatean S, Halue G, Nilmanat A, Luekamlung N, Klinbuayaem V, Chutanunta A, Kantipong P, Bowonwatanuwong C, Lertkoonalak R, Leenasirimakul P, Tansuphasawasdikul S, Sang-A-Gad P, Pathipvanich P, Thongbuaban S, Wittayapraparat P, Eiamsirikit N, Buranawanitchakorn Y, Yutthakasemsunt N, Winiyakul N, Decker L, Barbier S, Koetsawang S, Sirirungsi W, McIntosh K, Thanprasertsuk S, Lallemant M. Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in Thailand. PLoS Med. 2013 Aug; 10(8):e1001494.
    View in: PubMed
  3. Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Borkird T, Layangool P, Kamonpakorn N, Jitphiankha W, Kwanchaipanich R, Potchalongsin S, Lallemant M, Sirirungsi W, Goudeau A. Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. J Clin Virol. 2013 Oct; 58(2):415-21.
    View in: PubMed
  4. Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line Stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out Stavudine. J Infect Dis. 2013 Jun; 207 Suppl 2:S70-7.
    View in: PubMed
  5. Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S, Lallemant M, Goudeau A, Sirirungsi W. Prevalence, Risk Factors, and Impact of Isolated Antibody to Hepatitis B Core Antigen and Occult Hepatitis B Virus Infection in HIV-1-Infected Pregnant Women. Clin Infect Dis. 2013 Jun; 56(12):1704-12.
    View in: PubMed
  6. Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C. Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children. AIDS Behav. 2013 Jan; 17(1):193-202.
    View in: PubMed
  7. Collins IJ, Cairns J, Jourdain G, Fregonese F, Nantarukchaikul M, Lertpienthum N, Wannarit P, Attavinijtrakarn P, Layangool P, Le Coeur S, Lallemant M. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy. AIDS. 2012 Sep 24; 26(15):1943-52.
    View in: PubMed
  8. Duong T, Jourdain G, Ngo-Giang-Huong N, Le Cœur S, Kantipong P, Buranabanjasatean S, Leenasirimakul P, Ariyadej S, Tansuphasawasdikul S, Thongpaen S, Lallemant M. Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand. PLoS One. 2012; 7(8):e43375.
    View in: PubMed
  9. Khamduang W, Gaudy-Graffin C, Ngo-Giang-Huong N, Jourdain G, Moreau A, Luekamlung N, Halue G, Buranawanitchakorn Y, Kunkongkapan S, Buranabanjasatean S, Lallemant M, Sirirungsi W, Goudeau A. Long-term Hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. PLoS One. 2012; 7(7):e42184.
    View in: PubMed
  10. Fregonese F, Collins IJ, Jourdain G, Lecoeur S, Cressey TR, Ngo-Giang-Houng N, Banchongkit S, Chutanunta A, Techapornroong M, Lallemant M. Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand. J Acquir Immune Defic Syndr. 2012 May 1; 60(1):91-8.
    View in: PubMed
  11. Thenin S, Samleerat T, Tavernier E, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Barin F, Braibant M. Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties. Virology. 2012 Apr 25; 426(1):12-21.
    View in: PubMed
  12. Ngo-Giang-Huong N, Jourdain G, Amzal B, Sang-a-gad P, Lertkoonalak R, Eiamsirikit N, Tansuphasawasdikul S, Buranawanitchakorn Y, Yutthakasemsunt N, Mekviwattanawong S, McIntosh K, Lallemant M. Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis. PLoS One. 2011; 6(11):e27427.
    View in: PubMed
  13. Khamduang W, Jourdain G, Sirirungsi W, Layangool P, Kanjanavanit S, Krittigamas P, Pagdi K, Somsamai R, Sirinontakan S, Hinjiranandana T, Ardonk W, Hongsiriwon S, Nanta S, Borkird T, Lallemant M, McIntosh K, Ngo-Giang-Huong N. The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers. J Acquir Immune Defic Syndr. 2011 Oct 1; 58(2):188-92.
    View in: PubMed
  14. Lallemant M, Chang S, Cohen R, Pecoul B. Pediatric HIV--a neglected disease? N Engl J Med. 2011 Aug 18; 365(7):581-3.
    View in: PubMed
  15. Cressey TR, Urien S, Hirt D, Halue G, Techapornroong M, Bowonwatanuwong C, Leenasirimakul P, Treluyer JM, Jourdain G, Lallemant M. Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir. Ther Drug Monit. 2011 Feb; 33(1):25-31.
    View in: PubMed
  16. Collins IJ, Jourdain G, Hansudewechakul R, Kanjanavanit S, Hongsiriwon S, Ngampiyasakul C, Sriminiphant S, Technakunakorn P, Ngo-Giang-Huong N, Duong T, Le Coeur S, Jaffar S, Lallemant M. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010 Dec 15; 51(12):1449-57.
    View in: PubMed
  17. Lallemant M, Jourdain G. Preventing mother-to-child transmission of HIV—protecting this generation and the next. N Engl J Med. 2010 Oct 14; 363(16):1570-2.
    View in: PubMed
  18. Briand N, Le Coeur S, Jourdain G, Hotrawarikarn S, Sirinontakan S, Hinjiranandana T, Kanjanavanit S, Traisathit P, McIntosh K, Lallemant M. Hematological safety of perinatal exposure to zidovudine in uninfected infants born to HIV type 1-infected women in Thailand. AIDS Res Hum Retroviruses. 2010 Oct; 26(10):1163-6.
    View in: PubMed
  19. Cressey TR, Jourdain G, Rawangban B, Varadisai S, Kongpanichkul R, Sabsanong P, Yuthavisuthi P, Chirayus S, Ngo-Giang-Huong N, Voramongkol N, Pattarakulwanich S, Lallemant M. Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy. AIDS. 2010 Sep 10; 24(14):2193-200.
    View in: PubMed
  20. Jourdain G, Wagner TA, Ngo-Giang-Huong N, Sirirungsi W, Klinbuayaem V, Fregonese F, Nantasen I, Techapornroong M, Halue G, Nilmanat A, Wittayapraparat P, Chalermpolprapa V, Pathipvanich P, Yuthavisuthi P, Frenkel LM, Lallemant M. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure. Clin Infect Dis. 2010 May 15; 50(10):1397-404.
    View in: PubMed
  21. Lallemant M, Ngo-Giang-Huong N, Jourdain G, Traisaithit P, Cressey TR, Collins IJ, Jarupanich T, Sukhumanant T, Achalapong J, Sabsanong P, Chotivanich N, Winiyakul N, Ariyadej S, Kanjanasing A, Ratanakosol J, Hemvuttiphan J, Kengsakul K, Wannapira W, Sittipiyasakul V, Pornkitprasarn W, Liampongsabuddhi P, McIntosh K, Van Dyke RB, Frenkel LM, Koetsawang S, Le Coeur S, Kanchana S. Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine. Clin Infect Dis. 2010 Mar 15; 50(6):898-908.
    View in: PubMed
  22. Wagner TA, Kress CM, Beck I, Techapornroong M, Wittayapraparat P, Tansuphasawasdikul S, Jourdain G, Ngo-Giang-Huong N, Lallemant M, Frenkel LM. Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay. J Clin Microbiol. 2010 May; 48(5):1555-61.
    View in: PubMed
  23. Ngo-Giang-Huong N, Jourdain G, Sirirungsi W, Decker L, Khamduang W, Le Coeur S, Sirinontakan S, Somsamai R, Pagdi K, Hemvuttiphan J, McIntosh K, Barin F, Lallemant M. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis. 2010 Jul; 14(7):e602-7.
    View in: PubMed
  24. Cressey TR, Lallemant M. Pharmacogenomics and the prevention of mother-to-child transmission of HIV. Pharmacogenomics. 2010 Jan; 11(1):1-4.
    View in: PubMed
  25. Chantarangsu S, Cressey TR, Mahasirimongkol S, Capparelli E, Tawon Y, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Chantratita W. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women. J Antimicrob Chemother. 2009 Dec; 64(6):1265-73.
    View in: PubMed
  26. Traisathit P, Mary JY, Le Coeur S, Thantanarat S, Jungpichanvanich S, Pornkitprasarn W, Gomutbutra V, Matanasarawut W, Wannapira W, Lallemant M. Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV. J Obstet Gynaecol Res. 2009 Apr; 35(2):225-33.
    View in: PubMed
  27. Cailhol J, Jourdain G, Coeur SL, Traisathit P, Boonrod K, Prommas S, Putiyanun C, Kanjanasing A, Lallemant M. Association of low CD4 cell count and intrauterine growth retardation in Thailand. J Acquir Immune Defic Syndr. 2009 Apr 1; 50(4):409-13.
    View in: PubMed
  28. Samleerat T, Thenin S, Jourdain G, Ngo-Giang-Huong N, Moreau A, Leechanachai P, Ithisuknanth J, Pagdi K, Wannarit P, Sangsawang S, Lallemant M, Barin F, Braibant M. Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology. 2009 May 10; 387(2):388-94.
    View in: PubMed
  29. Pornprasert S, Mary JY, Faye A, Leechanachai P, Limtrakul A, Rugpao S, Sirivatanapa P, Gomuthbutra V, Matanasaravoot W, Le Coeur S, Lallemant M, Barré-Sinoussi F, Menu E, Ngo-Giang-Huong N. Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine. Curr HIV Res. 2009 Mar; 7(2):211-7.
    View in: PubMed
  30. Briand N, Pornprasert S, Ngo-Giang-Huong N, Galactéros F, Pissard S, Tatu T, Sanguansermsri T, Jourdain G, Lallemant M, Le Coeur S. Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand. Antivir Ther. 2009; 14(1):117-22.
    View in: PubMed
  31. Ngo-Giang-Huong N, Khamduang W, Leurent B, Collins I, Nantasen I, Leechanachai P, Sirirungsi W, Limtrakul A, Leusaree T, Comeau AM, Lallemant M, Jourdain G. Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings. J Acquir Immune Defic Syndr. 2008 Dec 15; 49(5):465-71.
    View in: PubMed
  32. Samleerat T, Braibant M, Jourdain G, Moreau A, Ngo-Giang-Huong N, Leechanachai P, Hemvuttiphan J, Hinjiranandana T, Changchit T, Warachit B, Suraseranivong V, Lallemant M, Barin F. Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AE. J Infect Dis. 2008 Sep 15; 198(6):868-76.
    View in: PubMed
  33. Cressey TR, Green H, Khoo S, Treluyer JM, Compagnucci A, Saidi Y, Lallemant M, Gibb DM, Burger DM. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children. Clin Infect Dis. 2008 May 15; 46(10):1601-8.
    View in: PubMed
  34. McIntyre J, Lallemant M. Recent advances in the prevention of mother-to-child transmission. Curr Opin HIV AIDS. 2008 Mar; 3(2):136-8.
    View in: PubMed
  35. McIntyre J, Lallemant M. The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure? Curr Opin HIV AIDS. 2008 Mar; 3(2):139-45.
    View in: PubMed
  36. Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis. 2007 Dec 1; 196(11):1629-36.
    View in: PubMed
  37. Arvold ND, Ngo-Giang-Huong N, McIntosh K, Suraseranivong V, Warachit B, Piyaworawong S, Changchit T, Lallemant M, Jourdain G. Maternal HIV-1 DNA load and mother-to-child transmission. AIDS Patient Care STDS. 2007 Sep; 21(9):638-43.
    View in: PubMed
  38. Cressey TR, Nangola S, Tawon Y, Pattarawarapan M, Lallemant M, Tayapiwatana C. Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2007 Sep; 51(9):3361-3.
    View in: PubMed
  39. Chantarangsu S, Cressey T, Mahasirimongkol S, Tawon Y, Ngo-Giang-Huong N, Jourdain G, Lallemant M, Chantratita W. Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism. Mol Cell Probes. 2007 Oct-Dec; 21(5-6):408-11.
    View in: PubMed
  40. Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, Chanpoo T, Traisathit P, McIntosh K, Le Coeur S. Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials. 2007; 2(4):e11.
    View in: PubMed
  41. Cressey TR, Lallemant M. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update. Infect Genet Evol. 2007 Mar; 7(2):333-42.
    View in: PubMed
  42. Cressey TR, Leenasirimakul P, Jourdain G, Tawon Y, Sukrakanchana PO, Lallemant M. Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006 Jul; 42(3):387-9.
    View in: PubMed
  43. Barin F, Jourdain G, Brunet S, Ngo-Giang-Huong N, Weerawatgoompa S, Karnchanamayul W, Ariyadej S, Hansudewechakul R, Achalapong J, Yuthavisuthi P, Ngampiyaskul C, Bhakeecheep S, Hemwutthiphan C, Lallemant M. Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1. J Infect Dis. 2006 Jun 1; 193(11):1504-11.
    View in: PubMed
  44. Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Pediatr Infect Dis J. 2006 Apr; 25(4):325-32.
    View in: PubMed
  45. Le Coeur S, Halembokaka G, Khlat M, Brouard N, Purhuence F, M'Pelé P, Baty G, Barin F, Lallemant M. Impact of AIDS on adult mortality: a morgue-based study in Pointe-Noire, Republic of Congo. AIDS. 2005 Oct 14; 19(15):1683-7.
    View in: PubMed
  46. Cressey TR, Leenasirimakul P, Jourdain G, Tod M, Sukrakanchana PO, Kunkeaw S, Puttimit C, Lallemant M. Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability. J Antimicrob Chemother. 2005 Jun; 55(6):1041-4.
    View in: PubMed
  47. Cressey TR, Jourdain G, Lallemant MJ, Kunkeaw S, Jackson JB, Musoke P, Capparelli E, Mirochnick M. Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2005 Mar 1; 38(3):283-8.
    View in: PubMed
  48. Lallemant M, Jourdain G, Le Coeur S, Ngo-Giang-Huong N, Thaineua V. [Prevention of mother-to-child transmission of HIV: a simple and highly efficacious regimen]. Med Sci (Paris). 2005 Jan; 21(1):28-9.
    View in: PubMed
  49. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, Ariyadej S, Leenasirimakul P, Hammer S, Lallemant M. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med. 2004 Jul 15; 351(3):229-40.
    View in: PubMed
  50. Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004 Jul 15; 351(3):217-28.
    View in: PubMed
  51. Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Antivir Ther. 2004 Apr; 9(2):179-85.
    View in: PubMed
  52. Jiang H, Deeks SG, Kuritzkes DR, Lallemant M, Katzenstein D, Albrecht M, DeGruttola V. Assessing resistance costs of antiretroviral therapies via measures of future drug options. J Infect Dis. 2003 Oct 1; 188(7):1001-8.
    View in: PubMed
  53. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med. 2000 Oct 5; 343(14):982-91.
    View in: PubMed
  54. Lallemant M, McIntosh K, Jourdain G, Le Coeur S, Vithayasai V, Lee TH, Hammer S, Prescott N, Essex M. Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World. N Engl J Med. 1998 Mar 19; 338(12):839-40; author reply 840-1.
    View in: PubMed
  55. Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, Weinstein MC. Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis Making. 1997 Oct-Dec; 17(4):455-63.
    View in: PubMed
  56. Lallemant M, Le Coeur S, McIntosh K, Brennan T, Gelber R, Lee TH, Hammer S, Essex M, Vithayasai V, Sirivatanapa P, et al. AZT trial in Thailand. Science. 1995 Nov 10; 270(5238):899-900.
    View in: PubMed
  57. Lallemant M, Le Coeur S. [Clinical experimentation with HIV vaccines: scientific and ethical dilemmas]. Hist Philos Life Sci. 1995; 17(1):151-69.
    View in: PubMed
  58. Lallemant M, Le Coeur S, Samba L, Cheynier D, M'Pelé P, Nzingoula S, Essex M. Mother-to-child transmission of HIV-1 in Congo, central Africa. Congolese Research Group on Mother-to-Child Transmission of HIV. AIDS. 1994 Oct; 8(10):1451-6.
    View in: PubMed
  59. Lallemant M, Baillou A, Lallemant-Le Coeur S, Nzingoula S, Mampaka M, M'Pelé P, Barin F, Essex M. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet. 1994 Apr 23; 343(8904):1001-5.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Lallemant's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_